RiboaptDB: A comprehensive database of ribozymes and aptamers

BMC Bioinformatics

Volumn 7, Issue SUPPL.2, 2006, Pages

  Thodima, Venkata ^a   Pirooznia, Mehdi ^a   Deng, Youping ^a  

^a University of Southern Mississippi   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER SEQUENCES; BINDING POCKETS; COMBINATORIAL APPROACH; FUNCTIONAL NUCLEIC ACIDS; INDIVIDUAL FEATURES; RANDOM SEQUENCE; SEQUENCE DATABASE; SEQUENCE INFORMATIONS;

DATABASE SYSTEMS; EXPERIMENTS; INORGANIC CHEMICALS; RNA;

DNA SEQUENCES;

APTAMER; NUCLEIC ACID; RIBOZYME;

ACCESS TO INFORMATION; ARTICLE; COMPUTER INTERFACE; COMPUTER PROGRAM; DIAGNOSTIC VALUE; IN VITRO STUDY; INTERNET; NUCLEOTIDE SEQUENCE; ONLINE SYSTEM; RIBOAPT DATABASE; SEQUENCE ANALYSIS; SEQUENCE DATABASE; SEQUENCE HOMOLOGY; BIOLOGY; CHEMISTRY; DNA SEQUENCE; METHODOLOGY; NUCLEIC ACID DATABASE;

APTAMERS, NUCLEOTIDE; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; INTERNET; RNA, CATALYTIC; SEQUENCE ANALYSIS, DNA; SOFTWARE DESIGN;

EID: 33947314593     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-7-S2-S6     Document Type: Article

References (45)

1. Jaeger L: The New World of ribozymes. Curr Opin Struct Biol 1997, 7(3):324-335.
2. Kumar PK, Ellington AD: Artificial evolution and natural ribozymes. Faseb J 1995, 9(12):1183-1195.
3. Stull RA, Szoka FC Jr: Antigene, ribozyme and aptamer nucleic acid drugs: Progress and prospects. Pharm Res 1995, 12(4):465-483.
4. Tang J, Breaker RR: Rational design of allosteric ribozymes. Chem Biol 1997, 4(6):453-459.
5. Murakami H, Suga S: [Artificial ribozymes: selection and application for nonnatural amino acid mutagenesis]. Tanpokushitsu Kakusan Koso 2003, 48(11 Suppl): 1511-1518.
6. Atkins D, Gerlach WL: Artificial ribozyme and antisense gene expression in Saccharomyces cerevisiae. Antisense Res Dev 1994, 4(2):109-117.
7. Jaschke A: Artificial ribozymes and deoxyribozymes. Curr Opin Struct Nat 2001, 11(3):321-326.
8. Joseph S, Berzal-Herranz A, Chowrira BM, Butcher SE, Burke JM: Substrate selection rules for the hairpin ribozyme determined by in vitro selection, mutation, and analysis of mismatched substrates. Genes Dev 1993, 7(1):130-138.
9. Brackett DM, Dieckmann T: Aptamer to Ribozyme: The Intrinsic Catalytic Potential of a Small RNA. Chembiochem 2006, 7(5):839-843.
10. NimjAe SM, Rusconi CP, Sullenger BA: Aptamers: an emerging class of therapeutics. Annu Rev Med 2005, 56:555-583.
11. Sen D: Aptamer rivalry. Chem Nat 2002, 9(8):851-852.
12. White RR, Sullenger BA, Rusconi CP: Developing aptamers into therapeutics. J Clin Invest 2000, 106(8):929-934.
13. Brody EN, Gold L: Aptamers as therapeutic and diagnostic agents. J Biotechnol 2000, 74(1):5-13.
14. Klug SJ, Famulok M: All you wanted to know about SELEX. Mol Biol Rep 1994, 20(2):97-107.
15. Eaton BE: The joys of in vCtro selection: chemically dressing oligonucleotides to satiate protein targets. Curr Opin Chem Biol 1997, 1(1):10-16.
16. Stoltenburg R, Reinemann C, Strehlitz B: FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 2005, 383(1):83-91.
17. Huizenga DE, Szostak JW: A DNA aptamer that binds adenosine and ATP. Biochemistry 1995, 34(2):6S6-665.
18. Sazani PL, Larralde R, Szostak JW: A small aptamer with strong and specific recognition of the triphosphate of ATP. J Am Chem Soc 2004, 126(27):8370-8371.
19. Sekiya S, Noda K, Nishikawa F, Yokoyama T, Kumar PK, Nishikawa S: Characterization and Application of a Novel RNA Aptamer against the Mouse Prion Protein. J Biochem (Tokyo) 2006, 139(3):383-390.
20. Hale SP, Schimmel P: Protein synthesis editing by a DNA aptamer. Proc Nad Acad Sci U S A 1996, 93(7):2755-2758.
21. Yang Y, Kochoyan M, Burgstaller P, Westhof E, Famulok M: Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy. Science 1996, 272(5266):1343-1347.
22. Mitani Y, Nakayama T, Harbers M, Hayashizakii Y: Aptamer-dependent full-length cDNA synthesis by overlap extension PCR. Biotechniques 2004, 37(1):128-129.
23. Meyers LA, Lee JF, Cowperthwaite M, Ellington AD: The robustness of naturally and artificially selected nucleic acid secondary structures. J Mol Evol 2004, 58(6):681-691.
24. Kumar RM, Joyce GF: A modular, bifunctional RNA that integrates itself into a target RNA. Proc Natl Acad Sci U S A 2003, 100(17):9738-9743.
25. Hamaguchi N, Ellington A, Stanton M: Aptamer beacons for the direct detection of proteins. Anal Biochem 2001, 294(2):126-131.
26. Burgstaller P, JenAe A, Blind M: Aptamers and aptazymes: accelerating small molecule drug discovery. Curr Opin Drug Discov Devel 2002, 5(5):690-700.
27. Sanghvi YS, Schulte M: TTerapeutic oligonucleotides: the state-of-the-art in purification technologies. Curr Opin Drug Discov Devel 2004, 7(6):765-776.
28. Ogawa A, Tomita N, Kikuchi N, Sando S, Aoyama Y: Aptamer selection for the inhibition of cell adhesion with fibronectin as target. Bioorg Med Chem Lett 2004, 14(15):4001-4004.
29. Becker RC, Rusconi C, Sullenger B: Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application. Thromb Hoemost 2005, 93(6):1014-1020.
30. Gokulrangan G, Unruh JR, Holub DF, Ingram B, Johnson CK, Wilson GS: DNA aptamer-based bioanalysis of IgE by fluorescence anisotropy. Anal Chem 2005, 77(7):1963-1970.
31. Lee JH, Canny MD, De Erkenez A, Krilleke D, Ng YS, Shima DT, Pardi A, Jucker F: A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF 165. Proc Natl Acad Sci U S A 2005, 102(52):18902-18907.
32. Akiyama H, Kachi S, RL ES, Umeda N, Hackett SF, McCauley D, McCauley T, Zoltoski A, Epstein DM, Campochiaro PA. Intraocular injection of an aptamer that binds PDGF-B: A potential treatment for proliferative retinopathies. J Cell Physiol 2006, 207(2):407-412.
33. Yamamoto-Fujita R, Kumar PK: Aptamer-derived nucleic acid oligos: applications to develop nucleic acid chips to analyze proteins and small ligands. Anal Chem 2005, 77(17):5460-5466.
34. Tombelli S, Minunni M, Luzi E, Mascini M: Aptamer-based biosensors for the detection of HIV-I Tat protein. Biaelectrochemistry 2005, 67(2):135-141.
35. Stadtherr K, Wolf H, Lindner P: An aptamer-based protein biochip. Anal Chem 2005, 77(11):437-3443.
36. Robertson MP, Ellington AD: Design and optimization of effector-activated ribozyme ligases. Nucleic Acids Res 2000, 28(8):1751-1759.
37. Patel DJ, Suri AK, Jiang F, Jiang L, Fan P, Kumar RA, Nonin S: Structure, recognition and adaptive binding in RNA aptamer complexes. J Mol Biol 1997, 272(5):645-664.
38. Lee JF, Hesselberth JR, Meyers LA, Ellington AD: Aptamer database. Nucleic Acids Res 2004, 32(Database issue):D95-100.
39. Ponomarenko JV, Orlova GV, Frolov AS, Gelfand MS, Ponomarenko MP: SELEX_DB: A database on in vitro selected oligomers adapted for recognizing natural sites and for analyzing both SNPs and site-directed mutagenesis data. Nucleic Acids Res 2002, 30(1):195-199.
40. [http://www.mysql.com].
41. [http://www.php.com].
42. Shoji Y, Shimada J, Mizushima Y: Drug delivery system to control infectious diseases. Curr Pharm Des 2002, 8(6):455-46S.
43. Silverman SK: Rube Goldberg goes (ribo)nuclear? Molecular switches and sensors made from RNA. Rna 2003,9(4):377-383.
44. Soukup GA, Breaker RR: Nucleic acid molecular switches. Trends Biotechnol 1999, 17(12):469-476.
45. [http://www.archemix.com].